[Continuous predetermined insulin infusion in insulin-dependent diabetes mellitus (author's transl)].
At the present, prognosis of insulin-dependent diabetes depends on it's degenerative complications. Many studies have confirmed that the incidence of severe degenerative complications of early onset parallels the degree of metabolic unbalance. Unfortunately, in many diabetic patients satisfactory metabolic control is difficult to ensure because of the irregular absorption of insulin injected discontinuously in subcutaneous tissues. This is true even under strict diet conditions. Continuous insulin infusion at a predetermined dosage was therefore suggested. Data on basic requirements is provided by an artificial pancreas. Satisfactory results have already been reported with intravenous and subcutaneous routes. Intramuscular and intraperitoneal routes are at present under trial. The use of portable pumps facilitates these techniques. The insulin dosage must be correctly determined and adjusted to the patient's diet and activity. In brittle diabetes, these methods can provide, at least temporarily, a satisfactory metabolic balance, and useful data for adjusting further therapy.
D000328:Adult; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007263:Infusions, Parenteral / Q000379:methods; D007328:Insulin / Q000097:blood; D007332:Insulin Infusion Systems; D009132:Muscles; D010529:Peritoneal Cavity; D012867:Skin
D007328:Insulin
Insulinothérapie continue et préprogrammée du diabétique insulinoprive.